Gynecology
FRIDAY, NOVEMBER 20
| 09:00-10:30 | CONTRACEPTION: THE UNDER-APPRECIATED BENEFITS |
Hall II |
| Chairpersons | Christian Egarter, Austria Johannes Bitzer, Switzerland |
|
| 09:00-09:25 | Irritable bowel syndrome Vincenzo Stanghellini, Italy |
|
| 09:25-09:50 | Asthma and rheumatoid arthritis Alessandra Graziottin, Italy |
|
| 09:50-10:15 | Optimizing psychosexual health with perimenopausal contraception Johannes Bitzer, Switzerland |
|
| 10:15-10:30 | Discussion | |
| 10:30-11:00 | VIRTUAL EXHIBITION AND E-POSTER VIEWING
|
EXHIBITION AND E-POSTER HALL |
| 11:00-12:30 | ADVANCES IN HORMONAL AND NON-HORMONAL RESEARCH |
Hall II |
| Chairperson | Mark Brincat, Malta | |
| 11:00-11:40 11:00 11:15 11:30 |
Debate: Should androgens be routinely offered to optimize quality of life in menopause? For: Alessandra Graziottin, Italy Against: Johannes Bitzer, Switzerland Discussion |
|
| 11:40-12:05 | How to overcome hormone resistance? Ludwig Kiesel, Germany |
|
| 12:05-12:30 | New SERMS/TSECS: Can they be an HRT substitute? Santiago Palacios, Spain |
|
| 12:30-15:05 | VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS | VARIOUS HALLS |
| 12:30-14:00 | NON-ABLATIVE AND MICRO-ABLATIVE LASERS IN GYNECOLOGY | Hall II |
| Capsule | LASER in medicine stands for a number of diverse devices. They radiate different energy at different wavelengths and produce different effects in different tissues. Er:YAG and CO2 lasers have been introduced, through last decade, for gynecology applications. Growing evidence supports non-ablative, and micro-ablative laser technology as an effective intervention for stress urinary icontinence, vulvo-vaginal atrophy, lichen sclerosus atrophycus, vaginal relaxation, etc. Despite of warnings from leading international organizations against the use of energy-based devices (EBDs) in certian fields of gynelology, contemporary evidence, that is going to be presented in this symposium, confirm safety and efficacy of laser treatment for genitourinary syndrome of menopause (GSM). | |
| Chairperson | Ivan Fistonić, Croatia | |
| 12:30-12:50 | Laser based vaginal treatments: Physical principles and biological effect Menachem Alcalay, Israel |
|
| 12:50-13:10 | CO2 laser applications in gynecology Stefano Salvatore, Italy |
|
| 13:10-13:30 | Potential of laser therapy in vulvar pathologies Mark Brincat, Malta |
|
| 13:30-13:50 | Er: YAG vaginal laser therapy – hype or established treatment? Ivan Fistonić, Croatia |
|
| 13:50-14:00 | Discussion | |
| 14:00-14:05 | BREAK |
| 14:05-15:05 | INDUSTRY SUPPORTED SESSION |
Hall II |
| 15:05-15:10 | BREAK |
| 15:10-16:40 | VULVAR PAIN AND CO-MORBITIES | Hall II |
| Chairperson | Ludwig Kiesel, Germany |
|
| 15:10-15:35 | Vulvar pains and co-morbidities: Data from 1183 cases Alessandra Graziottin, Italy |
|
| 15:35-16:00 | Vagina as an androgen target Linda Vignozzi, Italy |
|
| 16:00-16:40 16:00 16:15 16:30| |
Debate: Is laser treatment first line choice for Genitourinary Syndrome of Menopause (GSM)? Yes: Zdenko Vizintin, Slovenia No: Tim Hillard, UK Discussion |
|
| 16:40-17:00 | VIRTUAL EXHIBITION AND E-POSTER VIEWING
|
EXHIBITION AND E-POSTER HALL |
| 17:00-18:30 | HPV | Hall II |
| Chairperson | Xavier Bosch, Spain | |
| 17:00-17:20 | Natural history of HPV among females: Implications for control Anna Barbara Moscicki, USA |
|
| 17:20-17:40 |
Lessons learned from CC screening in KP: Intervals, primary HPV testing, how to limit the harms of screening, management by individual risk and impact of HPV vaccines |
|
| 17:40-18:00 |
What is new in preventive and therapeutic vaccines |
|
| 18:00-18:20 |
Real world effectiveness and duration of protection of HPV vaccination |
|
| 18:20-18:30 |
Q&A |
|
SATURDAY, NOVEMBER 21
| 09:00-10:30 | OVARIAN CANCER – NEW INSIGHTS AND CURRENT TREATMENT STANDARDS | Hall II |
| Chairpersons | Jalid Sehouli, Germany Elena Braicu, Germany |
|
| 09:00-09:20 | Molecular understanding of ovarian cancer Elena Braicu, Germany |
|
| 09:20-09:45 | Current role of primary surgery Robert Armbrust, Germany |
|
| 09:45-10:05 | Maintenance therapy in advanced ovarian cancer Klaus Pietzner, Germany |
|
| 10:05-10:30 | Relapsed ovarian cancer Jalid Sehouli, Germany |
|
| 10:30-11:00 | VIRTUAL EXHIBITION AND E-POSTER VIEWING
|
EXHIBITION AND E-POSTER HALL |
| 11:00-12:30 | RECENT ADVANCES ON POI AND LINK WITH DNA REPAIR/CANCER GENES |
Hall II |
| Chairperson | Lisa Webber, UK | |
| 11:00-11:25 | BRCA2 and Fancm mutants in primary ovarian insufficiency without cancer or Fanconi anemia trait Micheline Misrahi, France |
|
| 11:25-11:55 | Understanding the genetics of POI is important in clinical practice for the management of affected women and their families Micheline Misrahi, France |
|
| 11:55-12:15 | Is there a need for a POI network/database? Nick Panay, UK |
|
| 12:15-12:30 | POI and National Genomics: The experience in England Brianna Cloke, UK |
|
| 12:30-15:05 | VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS | VARIOUS HALLS |
| 12:30-14:00 | PCOS AT MENOPAUSE |
Hall II |
| Chairperson | Santiago Palacios, Spain | |
| 12:30-13:00 | Is there an increased CVD risk in PCOS women? Bart Fauser, Netherlands |
|
| 13:00-13:30 | Delayed fertility and later menopause in PCOS Joop Laven, Netherlands |
|
| 13:30-14:00 | Should ovarian tissue reimplantation be considered for all women to postpone menopause? Mark Brincat, Malta |
|
| 14:00-14:05 | BREAK |
| 14:05-15:05 | ISMAAR SESSION: MILD IVF | Hall II |
| Chairperson | Rene Frydman, France | |
| 14:05-14:45 14:05 14:20 14:35 |
Debate: Should mild IVF be the new norm in the post-COVID era? For: Geeta Nargund, UK Against: Georg Griesinger, Germany Discussion |
|
| 14:45-15:05 | Ovarian placental shift Georg Griesinger, Germany |
|
| 15:05-15:10 | BREAK |
| 15:10-16:40 | ENDOMETRIOSIS |
Hall II |
| Chairpersons | Jessica Ybanez-Morano, USA Olivier Donnez, Belgium |
|
| 15:10-15:35 | Long term risk of cancer in women carrying unoperated ovarian endometriomas: Immediate surgery, delayed surgery or never surgery? Paolo Vercellini, Italy |
|
| 15:35-15:55 | State-of-the-art of medical therapy or how to explain pain in endometriosis Sylvia Mechsner, Germany |
|
| 15:55-16:20 | Special countercurrent lecture: The role of miRNA as a marker for endometriosis Ludwig Kiesel, Germany |
|
| 16:20-16:40 | Vaginal microbiome: A new frontier into antibiotic resistant superbugs Gary Ventolini, USA |
|
| 16:40-17:00 | VIRTUAL EXHIBITION AND E-POSTER VIEWING
|
EXHIBITION AND E-POSTER HALL |
| 17:00-18:30 | SLS: THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS | Hall II |
| Chairperson | Jessica Ybanez-Morano, USA |
|
| 17:00-17:20 | The future in fertility surgery Mona Orady, USA |
|
| 17:20-17:40 | Dealing with parametrium endometriosis Thiers Soares Raymundo, Brazil |
|
| 17:40-18:05 | Updates on reduced site laparoscopy Jessica Ybanez-Morano, USA |
|
| 18:05-18:30 | Stop resecting septum Fulco van der Veen, Netherlands |
|